Testing effectiveness (Phase 2)Study completedNCT01014988
What this trial is testing
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Who this might be right for
Influenza, Human
GlaxoSmithKline 202